Systematic review of long-acting injectable antipsychotic medications approved from 2008 to october 2024 and agents in phase 3.
Meyer A, Truman K, Totlani J, William C, Brown H, Shah S, Hirsch D, Salem M, Chang T, Abdelsalam R, Renteria S, Murphy N, Hedrick R, Danovitch I, Pechnick RN, IsHak WW.
Meyer A, et al. Among authors: chang t.
Int J Psychiatry Med. 2024 Dec 19:912174241310091. doi: 10.1177/00912174241310091. Online ahead of print.
Int J Psychiatry Med. 2024.
PMID: 39703084
Review.